Depression and Anxiety: Effect on the Migraine-Obesity Relationship

• Published in: Headache 2007-06, Vol.47 (6), p.866-875
• Main Authors: Tietjen, Gretchen E., Peterlin, B. Lee, Brandes, Jan L., Hafeez, Faizan, Hutchinson, Susan, Martin, Vincent T., Dafer, Rima M., Aurora, Sheena K., Stein, Michael R., Herial, Nabeel A., Utley, Christine, White, Leah, Khuder, Sadik A.
• Format: Article
• Language: English
• Subjects: Adult; anxiety; Anxiety - epidemiology; Biological and medical sciences; Body Mass Index; Cardiovascular system; Comorbidity; Cross-Sectional Studies; depression; Depression - epidemiology; Female; Humans; Male; Medical sciences; Middle Aged; migraine; Migraine Disorders - epidemiology; Migraine Disorders - psychology; Neurology; Neuropharmacology; obesity; Obesity - epidemiology; Obesity - psychology; Pharmacology. Drug treatments; Prevalence; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Vascular diseases and vascular malformations of the nervous system; Vasodilator agents. Cerebral vasodilators
• ISSN: 0017-8748; 1526-4610
• DOI: 10.1111/j.1526-4610.2007.00810.x

Objective.—To discern the effects of depression and anxiety on the migraine–obesity relationship. Background.—Migraine and obesity are highly prevalent conditions and are both independently linked to psychiatric conditions, mainly depression and anxiety. Methods.—Data are from an ongoing cross‐sectional multicenter study on comorbid conditions in clinic patients seeking treatment for headache. The diagnosis of migraine was determined by the examining physician based on the International Classification of Headache Disorders (ICHD)‐II criteria. Participants completed a self‐administered questionnaire with information on demographics, headache features, and physician‐diagnosed comorbid medical and psychiatric disorders. The questionnaire included scales for measuring current depression (PHQ‐9), anxiety (BAI), and headache‐related disability (HIT‐6). Results.—A total of 721 migraineurs (88% women) from 8 different headache treatment centers were included in this study (mean age = 42 years, SD = 12). Aura was reported in 45% and chronic headache (≥15 headache days/month) in 35% of the participants. Prevalence of obesity in our population was 30% and only 38% had normal weight. Obesity was more common in men (P= .004), African Americans (P= .026), and in lower education (P= .05) and household income (P=.05) groups. Current depression (PHQ‐9 score ≥10) was noted in 42% and current anxiety (BAI score ≥8) in 70% of the obese migraineurs. In ordinal logistic regression, obesity was associated with current depression (odds ratio [OR]= 1.86, 95% confidence interval [CI]: 1.25 to 2.78) and anxiety (OR = 1.58, 95% CI: 1.12 to 2.22). A significant effect of depression on the body mass index (BMI) and headache frequency relationship was noted. Obese migraineurs with depression were more likely to have higher headache frequency (OR = 4.16, 95% CI: 1.92 to 8.99) and headache‐related disability (OR = 7.10, 95% CI: 2.69 to 18.77) compared to normal weight migraineurs without depression. Similarly, obese migraineurs with anxiety were more likely to have higher headache frequency (OR = 1.96, 95% CI: 1.07 to 3.61) and headache‐related disability (OR = 3.59, 95% CI: 1.64 to 7.86) compared to normal weight migraineurs without depression. Compared to migraineurs with either current depression or anxiety, those with both these conditions were more likely to have higher headache frequency (OR = 3.18, 95% CI: 1.86 to 5.43) and headache disability (OR = 6.13, 95% CI: 2.58 to 14.59). Co